The global Large Molecule Bioanalytical Testing Services Market size was valued at USD 1.8 billion in 2023, and the market is projected to reach USD 3.3 billion by the end of 2030, with growth at a CAGR of 9.1% during the forecast report 2023-2030.
The industry that offers services linked to the examination of large molecules, like proteins, antibodies, and nucleic acids in biological samples, is known as the "large molecule bioanalytical testing services market." To assure the quality, safety, and efficacy of biologics such as monoclonal antibodies, vaccines, and gene treatments, this kind of testing is frequently carried out during development.
Increasing demand for biologics and the complexity of these molecules have led to growth in the market for large-molecule bioanalytical testing services in recent years. Many assays, including immunoassays, cell-based assays, and chromatography, are included in the services provided by this sector.
The growing prevalence of chronic diseases, the rising need for individualized care, and the increased use of biologics across a range of therapeutic disciplines are some of the factors driving the market for large molecule bioanalytical testing services. Two other issues that the market must solve are the intricacy of large molecule analysis and the high cost of these services since they could make it challenging to achieve accurate and reliable results.
The market for large molecule bioanalytical testing services is anticipated to grow overall in the next years as a result of the expanding use of large molecule analysis in the fields of drug discovery and personalized medicine, as well as the growing demand for biologics.
The demand for these services is what drives the market for large molecule bioanalytical testing services. The following are some of the major forces currently influencing the market
Growing need for biologics: The demand for biologics including monoclonal antibodies, vaccines, and gene treatments is driving the demand for large molecule bioanalytical testing services. Biologics are being employed more frequently in the creation of personalized medicine as well as the treatment of chronic illnesses including cancer and autoimmune diseases.
The increasing complexity of large molecules: Drugs containing large molecules are getting more complicated, with more alterations and variants that may affect their quality, safety, and effectiveness. Large molecule bioanalytical testing services are in high demand due to the complexity of large molecules, which necessitates specific knowledge and tools for their analysis and testing.
Regulatory requirements: Strict regulatory standards that mandate significant testing and analysis are necessary for the development and approval of biologics. As a result, there is an increase in demand for large molecule bioanalytical testing services as businesses try to meet regulatory standards and release goods more swiftly.
Drug development is increasingly being outsourced, with many pharmaceutical and biotech businesses turning to contract research organizations (CROs) and other service providers for assistance. Due to CROs' desire to offer their clients a comprehensive spectrum of services, this is increasing demand for large molecule bioanalytical testing services.
Technological developments: large molecule bioanalytical testing is becoming faster, more effective, and more accurate thanks to technological developments including high-throughput screening and automated analytical equipment. As businesses look to capitalize on these technical breakthroughs to quicken their drug development operations, this is fueling demand for these services.
The market for large molecule bioanalytical testing services is anticipated to expand overall in the next years as a result of these and other factors that are influencing consumer demand for these products and services.
As per the report, the global Large Molecule Bioanalytical Testing Services Market is segmented into Type, Application, and Regions. The report covers detailed information on market size, Share, Growth, Value, Volume Analysis, Demand analysis, new market entry, competition insights, market drivers, challenges, opportunities, and Restraints. Further, company profile analysis, company revenue, Strategies, Sales, company acquisition, partnership, mergers, latest trends in the industry, regional and country-level insights, and competitive intelligence data is provided in the research report.
Further, the global market is geographically divided into major regions, and countries including North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Further, major countries focused in the global study report: United States, Canada, United Kingdom, Spain, Germany, Italy, France, Mexico, Russia, Ukraine, China, Japan, South Korea, India, Singapore, Malaysia, Australia, Qatar, Kingdom of Saudi Arabia, South Africa, Brazil, Argentina, and other countries are covered in the research study.
by Phase
• Preclinical
• Clinical
by Type
• Pharmacokinetics
• ADA
• Others
by Test
• ADME
• PD
• Bioavailability
• Bioequivalence
• Other Tests
by Therapeutic Area
• Oncology
• Infectious Diseases
• Cardiology
• Neurology
• Others
by End-Use
• Large Firms
• CROs & CMOs
• Sponsor Organizations
• Academic and Research Institutes
- North America
- Latin America
- Europe
- Middle East and Africa
- Asia Pacific
• North American market to remain in control over the global market during 2022-2030. In the North American region, the United States occupied the highest share of the market in this region, and the US country is projected to follow the same trend over the forecast time 2022-2030, followed by Canada.
• Europe holds the second largest share producer in the global Disposable Medical Sensors Market during the forecast period 2022-2030. Asia Pacific region is expected to be registered as the fastest-growing market in the global market by 2030.
• Most developing countries in the Asia Pacific remain the focus of leading Disposable Medical Sensors companies, with a large portion of these companies investing in new entry and business expansion strategies
• The market in the Middle East and Africa is projected to show prominent growth opportunities in the coming years from 2023-2030. Due to the rising focus from the government of the Middle East and African countries on emerging healthcare infrastructure manufacturing and distribution are mostly contributing to the global market in the MEA region.
• The Latin American Disposable Medical Sensors Market registered a substantial share of the global market in 2022, and it is projected to remain its presence in the market.
• Covance Inc.
• IQVIA Inc.
• Syneos Health Inc
• SGS SA
• Toxikon Inc
• Intertek Group plc
• Pace Analytical Services LLC
• ICON Plc
• Charles River Laboratories Inc.
• Thermo Fisher Scientific Corp
1. Executive Summary
1.1 Introduction to Large Molecule Bioanalytical Testing Services Markets
1.2 Large Molecule Bioanalytical Testing Services Market Size Outlook, 2021- 2030
1.3 Growth Opportunities in Large Molecule Bioanalytical Testing Services Industry
1.4 Winning Strategies for the post-pandemic future
2. Report Guide
2.1 Market Definition and Scope
2.2 Market Segmentation
2.3 Research Methodology
2.4 Forecast Methodology
2.5 List of Abbreviations
3. Growth Opportunity Analysis
3.1 Key Large Molecule Bioanalytical Testing Services Market Trends
3.2 Key Large Molecule Bioanalytical Testing Services Market Growth Drivers
3.3 Key Large Molecule Bioanalytical Testing Services Market Growth Restraints
4 Large Molecule Bioanalytical Testing Services Market Outlook – Scenario Analysis
4.1 Low Growth Case Scenario Forecasts
4.2 Reference Growth Case Scenario Forecasts
4.3 High Growth Case Scenario Forecasts
5. Large Molecule Bioanalytical Testing Services Market Segmentation- Outlook by Phase
5.1 Preclinical Market Outlook to 2030
5.2 Clinical Market Outlook to 2030
6. Large Molecule Bioanalytical Testing Services Market Segmentation- Outlook by Type
6.1 Pharmacokinetics Market Outlook to 2030
6.2 ADA Market Outlook to 2030
6.3 Others Market Outlook to 2030
7. Large Molecule Bioanalytical Testing Services Market Segmentation- Outlook by Test
7.1 ADME Market Outlook to 2030
7.2 PD Market Outlook to 2030
7.3 Bioavailability Market Outlook to 2030
7.4 Bioequivalence Market Outlook to 2030
7.5 Other Tests Market Outlook to 2030
8. Large Molecule Bioanalytical Testing Services Market Segmentation- Outlook by Therapeutic Area
8.1 Oncology Market Outlook to 2030
8.2 Infectious Diseases Market Outlook to 2030
8.3 Cardiology Market Outlook to 2030
8.4 Neurology Market Outlook to 2030
8.5 Others Market Outlook to 2030
9. Large Molecule Bioanalytical Testing Services Market Segmentation- Outlook by End-Use
9.1 Large Firms Market Outlook to 2030
9.2 CROs & CMOs Market Outlook to 2030
9.3 Sponsor Organizations Market Outlook to 2030
9.4 Academic and Research Institutes Market Outlook to 2030
10. North America Large Molecule Bioanalytical Testing Services Market Outlook and Opportunities to 2030
10.1 Market Snapshot, 2023
10.2 North America Large Molecule Bioanalytical Testing Services Market Growth Opportunities
10.3 North America Large Molecule Bioanalytical Testing Services Market Outlook by Application
10.4 North America Large Molecule Bioanalytical Testing Services Market Outlook by Type
10.5 North America Large Molecule Bioanalytical Testing Services Market Outlook by Country
10.6 United States Large Molecule Bioanalytical Testing Services Market Outlook
10.7 Canada Large Molecule Bioanalytical Testing Services Market Outlook
10.8 Mexico Large Molecule Bioanalytical Testing Services Market Outlook
11. Europe Large Molecule Bioanalytical Testing Services Market Outlook and Opportunities to 2030
11.1 Market Snapshot, 2023
11.2 Europe Large Molecule Bioanalytical Testing Services Market Outlook by Application
11.3 Europe Large Molecule Bioanalytical Testing Services Market Outlook by Type
11.4 Europe Large Molecule Bioanalytical Testing Services Market Outlook by Country
11.5 Germany Large Molecule Bioanalytical Testing Services Market Outlook
11.6 France Large Molecule Bioanalytical Testing Services Market Outlook
11.7 United Kingdom Large Molecule Bioanalytical Testing Services Market Outlook
11.8 Spain Large Molecule Bioanalytical Testing Services Market Outlook
11.9 Italy Large Molecule Bioanalytical Testing Services Market Outlook
11.10 Other Europe Large Molecule Bioanalytical Testing Services Market Outlook
12. Asia Pacific Large Molecule Bioanalytical Testing Services Market Outlook and Opportunities to 2030
12.1 Market Snapshot, 2023
12.2 Asia Pacific Large Molecule Bioanalytical Testing Services Market Outlook by Application
12.3 Asia Pacific Large Molecule Bioanalytical Testing Services Market Outlook by Type
12.4 Asia Pacific Large Molecule Bioanalytical Testing Services Market Outlook by Country
12.5 China Large Molecule Bioanalytical Testing Services Market Outlook
12.6 Japan Large Molecule Bioanalytical Testing Services Market Outlook
12.7 India Large Molecule Bioanalytical Testing Services Market Outlook
12.8 Other Asia Pacific Large Molecule Bioanalytical Testing Services Market Outlook
13. Latin America Large Molecule Bioanalytical Testing Services Market Outlook and Opportunities to 2030
13.1 Market Snapshot, 2023
13.2 Latin America Large Molecule Bioanalytical Testing Services Market Outlook by Application
13.3 Latin America Large Molecule Bioanalytical Testing Services Market Outlook by Type
13.4 Latin America Large Molecule Bioanalytical Testing Services Market Outlook by Country
13.5 Brazil Large Molecule Bioanalytical Testing Services Market Outlook
13.6 Argentina Large Molecule Bioanalytical Testing Services Market Outlook
13.7 Other Latin America Large Molecule Bioanalytical Testing Services Market Outlook
14. Middle East and Africa Large Molecule Bioanalytical Testing Services Market Outlook and Opportunities to 2030
14.1 Market Snapshot, 2023
14.2 Middle East and AfricaLarge Molecule Bioanalytical Testing Services Market Outlook by Application
14.3 Middle East and AfricaLarge Molecule Bioanalytical Testing Services Market Outlook by Type
14.4 Middle East and AfricaLarge Molecule Bioanalytical Testing Services Market Outlook by Country
14.5 Saudi Arabia Large Molecule Bioanalytical Testing Services Market Outlook
14.6 UAE Large Molecule Bioanalytical Testing Services Market Outlook
14.7 South Africa Large Molecule Bioanalytical Testing Services Market Outlook
14.8 Other Middle East and Africa Large Molecule Bioanalytical Testing Services Market Outlook
15 Profiles of major Large Molecule Bioanalytical Testing Services Companies
Covance Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
IQVIA Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Syneos Health Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
SGS SA
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Toxikon Inc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Intertek Group plc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Pace Analytical Services LLC
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
ICON Plc
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Charles River Laboratories Inc.
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
Thermo Fisher Scientific Corp
- Key Statistics
- Business Operations
- Products and Services Offered
- SWOT Analysis
- Financial Analysis
16. Appendix
16.1 Publisher’s Expertise
16.2 List of Tables and Charts
16.3 List of Exhibits
16.4 Legal Disclaimer
by Phase
• Preclinical
• Clinical
by Type
• Pharmacokinetics
• ADA
• Others
by Test
• ADME
• PD
• Bioavailability
• Bioequivalence
• Other Tests
by Therapeutic Area
• Oncology
• Infectious Diseases
• Cardiology
• Neurology
• Others
by End-Use
• Large Firms
• CROs & CMOs
• Sponsor Organizations
• Academic and Research Institutes